908 Devices (NASDAQ:MASS – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it contrast to its rivals? We will compare 908 Devices to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.
This is a breakdown of recent ratings and recommmendations for 908 Devices and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|908 Devices Competitors||154||689||953||28||2.47|
This table compares 908 Devices and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|908 Devices Competitors||-3,288.70%||4.83%||1.80%|
Insider & Institutional Ownership
79.2% of 908 Devices shares are owned by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 51.1% of 908 Devices shares are owned by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
908 Devices has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, 908 Devices’ rivals have a beta of 1.03, indicating that their average share price is 3% more volatile than the S&P 500.
Earnings and Valuation
This table compares 908 Devices and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|908 Devices||$42.21 million||-$22.17 million||-15.11|
|908 Devices Competitors||$2.66 billion||$435.24 million||10.95|
908 Devices’ rivals have higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
908 Devices beats its rivals on 7 of the 13 factors compared.
About 908 Devices (Get Rating)
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.